Full Press Release Details
PALO ALTO, Calif.--(BUSINESS WIRE)--November 23, 2011--Geron
Corporation; Amicus Therapeutics; Complete Genomics, Inc.; Archemix
Corp.; Neomend, Inc.; and TOPICA Pharmaceuticals, Inc. made the
following tribute to Alexander Barkas:
Our companies are greatly saddened to acknowledge the unexpected passing
of Alex Barkas on November 21, 2011.
Alex had an extraordinary relationship with all of us as an investor and
a member of our boards of directors. Throughout his many years of
service, Alex was a strong advocate for our companies, and for the
innovative technologies we pioneered. He had a remarkably incisive mind
for business. Coupled with his deep, intuitive understanding of science,
and his formidable intellect, he was an extremely able leader at our
companies, and within the broader biotechnology industry. Alex embodied
the essence of healthcare venture capital and through his passion for
science and nurturing emerging companies, he improved the lives of so
many patients. He will be deeply missed by many past and present
employees, as well as by his fellow directors and many friends within
our respective communities.
It is often said of great men that they are larger than life. Alex
Barkas was surely such a man, and we will treasure our memories of him
as a mentor, colleague and friend.
Anna Krassowska, Ph.D., 650-473-7765
Sara Pellegrino, 609-662-5044
Scott Sandler, 650-943-2788
Public Relations for Archemix Corp.
Kathryn Morris, 845-635-9828
Charity Azadian, 949-783-3447
for Topica Pharmaceuticals, Inc.
Joey Fleury, 415-946-1090